http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-9701661-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545 |
| filingDate | 1997-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23ad87a073a8e16178219fe69598f6d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bb557b723ea9073d7a58697f652afa7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c0e87272971de281cd6f72dc7fc2d55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0784b58af038479cebb3bdc49a1cfe08 |
| publicationDate | 1998-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HU-9701661-A2 |
| titleOfInvention | Pyridinium cephalosporin derivatives |
| abstract | The cephalosporin pyridinyl derivatives of formula (I) (wherein R1 is hydrogen, lower alkyl, cycloalkyl or acetyl), X is -CH = or -N =, n is 0, 1 or 2, m is 0 or 1, R2 is hydrogen, lower alkyl, β-hydroxyalkyl, benzyl or lower alkyl heterocyclic, while benzyl and heterocyclic may be unsubstituted, or at least one amino, carboxyl, halo, cyano, , lower alkyl, lower alkoxy or -CONR2, of which R is hydrogen or lower alkyl, or R2 is -CH2CONR4R5, naphth, of which R4 and R6 are independently alkyl, hydrogen is independently selected from hydrogen, hydrogen. or heterocyclic tubes, with phenyl, naphthyl or heterocycles being unsubstituted or at least bb may be substituted with an optionally protected hydroxyl tube, a fish gene, an optionally substituted lower alkoxy, w-hydroxyalkyl and / or cyano tube, or R4 and R5 together form a tube of formula (A), provided that heat, "in place of a pyridinyl ring is a pyridinyl-4-yl ring, m is 1) and their readily hydrolyzable esters, pharmaceutically acceptable salts of these compounds, and hydrates of the compounds of formula (I), their esters and salts are useful in the treatment and prevention of infectious diseases. ŕ |
| priorityDate | 1996-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 221.